Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Intra-abdominal Infections”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Testing effectiveness (Phase 2)Study completedNCT00621192
What this trial is testing

Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

Who this might be right for
Necrotizing EnterocolitisIntra-abdominal Infection
The Emmes Company, LLC 200
Testing effectiveness (Phase 2)Ended earlyNCT03354754
What this trial is testing

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra-abdominal Infections
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT00515034
What this trial is testing

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 146
Testing effectiveness (Phase 2)Looking for participantsNCT06794541
What this trial is testing

Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Who this might be right for
Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc 35
Large-scale testing (Phase 3)Study completedNCT01994993
What this trial is testing

Antibiotic Safety (SCAMP)

Who this might be right for
Complicated Intra Abdominal Infections
Michael Cohen-Wolkowiez 260
Post-approval studies (Phase 4)Study completedNCT00044928
What this trial is testing

Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Who this might be right for
Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 262
Not applicableStudy completedNCT00488488
What this trial is testing

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Who this might be right for
Infection
Pfizer 1,028
Post-approval studies (Phase 4)Study completedNCT00488306
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 50
Large-scale testing (Phase 3)Study completedNCT00136201
What this trial is testing

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 200
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Large-scale testing (Phase 3)Study completedNCT00210938
What this trial is testing

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Who this might be right for
Bacterial Infections and MycosesAppendicitisCholecystitis+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 478
Post-approval studies (Phase 4)Study completedNCT00157898
What this trial is testing

Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Who this might be right for
Complicated Intra-abdominal Infection
Merck Sharp & Dohme LLC 134
Large-scale testing (Phase 3)Study completedNCT03830333
What this trial is testing

Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)

Who this might be right for
Complicated Intra-abdominal Infections
Merck Sharp & Dohme LLC 268
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Large-scale testing (Phase 3)Study completedNCT01644643
What this trial is testing

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Who this might be right for
Complicated Urinary Tract InfectionComplicated Intra-abdominal Infection
Pfizer 345
Large-scale testing (Phase 3)Study completedNCT00492726
What this trial is testing

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Who this might be right for
Infection
Bayer 804
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)Study completedNCT03358576
What this trial is testing

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra Abdominal Infections
Iterum Therapeutics, International Limited 674
Large-scale testing (Phase 3)Looking for participantsNCT05148702
What this trial is testing

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

Who this might be right for
Complicated Intra-abdominal Infection
Sarah Cockayne 1,166
Load More Results